WPD Financial Statements From 2010 to 2026
WPD Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing WPD Pharmaceuticals' valuation are provided below:WPD Pharmaceuticals does not now have any fundamental gauges for analysis.
This module can also supplement various WPD Pharmaceuticals Technical models . Check out the analysis of WPD Pharmaceuticals Correlation against competitors.
Check WPD Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WPD Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . WPD financial statements analysis is a perfect complement when working with WPD Pharmaceuticals Valuation or Volatility modules.
WPD |
WPD Pharmaceuticals Company Price To Book Analysis
WPD Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current WPD Pharmaceuticals Price To Book | 107.84 X |
Most of WPD Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WPD Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, WPD Pharmaceuticals has a Price To Book of 107 times. This is 319.93% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The price to book for all United States stocks is notably lower than that of the firm.
WPD Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WPD Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare WPD Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WPD Pharmaceuticals competition to find correlations between indicators driving WPD Pharmaceuticals's intrinsic value. More Info.WPD Pharmaceuticals is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WPD Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About WPD Pharmaceuticals Financial Statements
WPD Pharmaceuticals stakeholders use historical fundamental indicators, such as WPD Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although WPD Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in WPD Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on WPD Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in WPD Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada. Wpd Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 19 people.
Currently Active Assets on Macroaxis
Other Information on Investing in WPD Pink Sheet
WPD Pharmaceuticals financial ratios help investors to determine whether WPD Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WPD with respect to the benefits of owning WPD Pharmaceuticals security.